The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OCOG-RATIONAL: A phase II randomized trial of optimal recurrence-directed therapy (RDT) without or with androgen-deprivation therapy (ADT) in radio-recurrent oligo-metastatic castrate sensitive prostate cancer (romCSPC).
 
Theodoros Tsakiridis
Honoraria - AstraZeneca; Sanofi
Research Funding - Astellas Pharma; Sanofi; Tolmar; Tolmar Canada
Travel, Accommodations, Expenses - Tolmar
 
Andre Gouveia
No Relationships to Disclose
 
Aruz Mesci
Honoraria - Novartis
Consulting or Advisory Role - Need
 
Peter Vavassis
Consulting or Advisory Role - Abbvie; Bayer; Knight Therapeutics; Novartis; Pfizer; Sumitomo Pharma Oncology; Tersera; Tolmar
Speakers' Bureau - Abbvie
Research Funding - Bayer; Johnson & Johnson/Janssen
 
Alejandro Berlin
Consulting or Advisory Role - Abbvie; Astellas Pharma; Ferring
Research Funding - Abbvie
 
Scott Morgan
Research Funding - Knight Therapeutics (Inst)
 
Nathan Perlis
Stock and Other Ownership Interests - Focal Healthcare
Honoraria - Abbvie; Knight Pharmaceuticals; TerSerra; Tolmar
Consulting or Advisory Role - Bayer; Spectracure; Tolmar
Research Funding - spectracure
Expert Testimony - Apotex
Travel, Accommodations, Expenses - Tersera; tolmar
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
John Thoms
Honoraria - Abbvie; Tersera; Tolmar
Consulting or Advisory Role - Tersera
 
Sebastien Hotte
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Scientific and Medical Affairs Inc; Bayer
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); SignalChem (Inst)
 
Jim Wright
No Relationships to Disclose